
Excision BioTherapeutics
Excision BioTherapeutics is focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. We are focused on developing gene editing medicines to eradicate or disrupt viral genes in human patients.
0
0
0
Key Info
- 2015 Founded
- Grater Ave, Collegeville, Pennsylvania, USA
- 49 Employees
- •••••••••
Team
Investments
There is no investment data on this organization.